Castle Biosciences, Inc. (CSTL)
38.19
-0.06
(-0.16%)
USD |
NASDAQ |
Dec 10, 13:22
Castle Biosciences Shareholders Equity (Quarterly): 467.05M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Delcath Systems, Inc. | 114.85M |
| Star Operating Cos., Inc. | 62.61M |
| EXACT Sciences Corp. | 2.501B |
| Illumina, Inc. | 2.381B |
| CytoSorbents Corp. | 9.02M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 562.79M |
| Total Liabilities (Quarterly) | 95.74M |
| Debt to Equity Ratio | 0.0795 |
| Current Ratio | 6.465 |
| Net Debt Paydown Yield | -0.36% |